About
Dialybrid aims at developing and commercializing novel arteriovenous vascular grafts for hemodialysis, based on the proprietary innovative technology named Silkothane®, a hybrid material combining silk fibroin and polyurethane.
Technologies
Outlook
Microsoft Office 365
WordPress.org
Google Tag Manager
Nginx
Mobile Friendly
Keywords
medical equipment manufacturing
regenerative medicine applications
regenerative medicine
natural and synthetic polymers
silkothane
nanofibrous meshes
bio-hybrid materials
natural polymer composites
semi-degradable vascular prostheses
tissue engineering
biomimetic nanostructure
biomedical engineering
early cannulation grafts
endogenous tissue regeneration
in situ tissue engineering
b2b
sag (silkothane arteriovenous graft)
vascular grafts
biocompatible materials
medical device innovation
hemodialysis access
healthcare equipment & supplies
nanostructured scaffolds
silk fibroin and polyurethane
vascular tissue engineering
biocompatibility
nanostructured biomaterials
biotechnology
silkothane technology
off-the-shelf vascular access
Company Information
-
Employees 7
-
Founded 2020
Location
32A Via Antonio Vivaldi, Cantu, Lombardy, Italy, 22063
